5:58 PM
 | 
Feb 04, 2013
 |  BC Extra  |  Financial News

Gilead beats Street

Gilead Sciences Inc. (NASDAQ:GILD) reported 4Q12 and 2012 earnings that beat analyst expectations. The company reported 4Q12 non-GAAP diluted EPS of $0.50, beating by $0.02 the Street's estimate of $0.48 and up...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >